Advertisement
UK markets close in 2 hours 24 minutes

  • FTSE 100

    7,864.89
    -100.64 (-1.26%)
     

  • FTSE 250

    19,470.21
    -228.68 (-1.16%)
     

  • AIM

    742.44
    -7.84 (-1.05%)
     

  • GBP/EUR

    1.1711
    +0.0000 (+0.00%)
     

  • GBP/USD

    1.2458
    +0.0012 (+0.10%)
     

  • Bitcoin GBP

    50,551.03
    -2,517.36 (-4.74%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • S&P 500

    5,061.82
    -61.59 (-1.20%)
     

  • DOW

    37,735.11
    -248.13 (-0.65%)
     

  • CRUDE OIL

    84.83
    -0.58 (-0.68%)
     

  • GOLD FUTURES

    2,390.90
    +7.90 (+0.33%)
     

  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     

  • HANG SENG

    16,248.97
    -351.49 (-2.12%)
     

  • DAX

    17,862.60
    -163.98 (-0.91%)
     

  • CAC 40

    7,970.06
    -75.05 (-0.93%)
     
Money:

How to avoid tax creep in retirement

The state pension went up 8.5% in April, but frozen thresholds mean pensioners will be paying more tax

GSK, NewLink working to bring Ebola vaccines online - WHO

Reuters - UK Focus

GENEVA, Oct 1 (Reuters) - Both GlaxoSmithKline and NewLink are working to boost their capacity to make Ebola vaccines, with a goal of a "very significant increase in scale during the first half of 2015", the World Health Organization (WHO) said on Wednesday.

Even (Taiwan OTC: 6436.TWO - news) under the best conditions, if the experimental vaccines are proven to be safe and confer protection in clinical trials, a significant number of doses will not be available until late in the first quarter of 2015, it said.

GSK and Newlink are conducting phase one trials currently or soon in more than 10 sites in Africa, Europe and North America, the United Nations agency said in a statement after hosting a two-day meeting of 70 experts.

(Reporting by Stephanie Nebehay; editing by Tom Miles)